April 29th 2025
Brett Casper explores the marketplace complexities that manufacturers face regularly.
April 16th 2025
The new firm—with 13 manufacturing facilities spanning France, Sweden, and Spain—will support the pharma supply chain through to commercialization.
March 12th 2025
The partnership focuses on enhancing the patient experience by providing greater affordability and access to specialty meds.
February 24th 2025
The injection for the treatment of psoriatic arthritis—among other indications—is a biosimilar to Stelara.
January 14th 2025
The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.
Immunoglobulin (IG) drives the blood-plasma therapeutics market
Even though recombinant-DNA biologics are displacing traditional blood-sourced therapeutics, maintaining stable supplies is still a problem
J. Knipper heads CBI conference on sampling management
The anatomy of an optimized sampling supply chain
Specialty pharma becomes 'hub enabled'
Call it the United Nations of Veeva OpenData
Database now covers 35 countries and 19 million HCPs
Use data analytics to monitor 340B discount drug pricing
Discerning how and where products are discounted is an expensive headache for manufacturers
Bringing value to healthcare: practical steps for getting to a market-based model
A new, market-driven model of drug development and commercialization is appearing*
Five tips to protect pharma brands online
MarkMonitor updates its surveillance surveys against counterfeiting and drug diversion
DEA meets with pharma supply chain leaders over opioid abuse--and that's the news
Government at all levels are trying to mobilize to address the crisis
NHIA finalizes standardized definitions for home infusion services
Advisory program makes data reporting more uniform
Identifying value in digital sales aids for pharma
New survey finds more digitally-savvy healthcare providers, challenging reps' presentation capabilities
Global vaccine R&D community mobilizes for Zika virus
Marken offers tailored logistics services to research community
New consulting resources for contract management, incentive compensation and regulatory
TGaS Advisors expands its roster of services
Vaccines manufacturers wrestle with public health policy
Good growth is occurring in the vaccine business, despite the hurdles of public perceptions and public-health funding shortfalls
The impact of the anti-vaccination lobby
Observational Research: Choosing the right research approach for the right question
Industry hit a record low number of FDA OPDP actions in 2015
Office of Prescription Drug Promotion finds little to complain about
A Conversation with Bill Roth, Blue Fin Group
CMS publishes the long-awaited AMP rule
'Average Manufacturer Price' is now a mostly settled matter
Mind your "Q"s: QPharma acquires Qforma
Combination expands breadth of commercialization and compliance services
FDA approved 45 new drugs in 2015--a new recent record
List includes 21 new orphan drugs, and of the 45, 15 are cold chain products
Dissecting the speed-to-therapy question
Are hubs a help or hindrance in getting patients on therapy?
Pediatric drug market finds its own pathway
Even with legislative incentives, pharma manufacturers struggle to cost-justify pediatric innovation
Deloitte healthcare consumer survey: more trust in pharma; more interaction over healthcare costs
Biennial survey finds growing awareness of information options by consumers
TMS Health steps more deeply into specialty services with acquisition of inVentiv's Patient Access Solutions (iPAS)
Xerox subsidiary expands its call-center operations to include specialty reimbursement services
Pharma is under-managing its multi-channel marketing efforts
Survey shows that most digital channels are still experiments with little oversight or follow-through
The business of orphan drugs is booming
With competing products and pricing pressure, the rare disease market is starting to resemble the conventional drug market
Shifts in the retail pharmacy landscape
Latest SK&A pharmacy data outlines retail channel
Moving the needle on diabetes
While the biopharma industry continues to develop better treatment options, there is a stronger focus on more intensive patient engagement
Patient-centric support for specialty drug therapy--a new model to address the needs of a changing patient population
Demand for McKesson Patient Relationship Solutions grows; also expanded AccessHealth services for pharmacies
Company will open a second call center, in Atlanta, GA, to provide support for patient-engagement and adherence programs